Open Access

Functional Impact of RNA editing and ADARs on regulation of gene expression: perspectives from deep sequencing studies

  • Hsuan Liu1, 2, 4,
  • Chung-Pei Ma1,
  • Yi-Tung Chen1,
  • Scott C Schuyler1, 3,
  • Kai-Ping Chang4, 5 and
  • Bertrand Chin-Ming Tan1, 3, 4Email author
Cell & Bioscience20144:44

DOI: 10.1186/2045-3701-4-44

Received: 13 May 2014

Accepted: 14 July 2014

Published: 19 August 2014

Abstract

Cells regulate gene expression at multiple levels leading to a balance between robustness and complexity within their proteome. One core molecular step contributing to this important balance during metazoan gene expression is RNA editing, such as the co-transcriptional recoding of RNA transcripts catalyzed by the adenosine deaminse acting on RNA (ADAR) family of enzymes. Understanding of the adenosine-to-inosine RNA editing process has been broadened considerably by the next generation sequencing (NGS) technology, which allows for in-depth demarcation of an RNA editome at nucleotide resolution. However, critical issues remain unresolved with regard to how RNA editing cooperates with other transcript-associated events to underpin regulated gene expression. Here we review the growing body of evidence, provided by recent NGS-based studies, that links RNA editing to other mechanisms of post-transcriptional RNA processing and gene expression regulation including alternative splicing, transcript stability and localization, and the biogenesis and function of microRNAs (miRNAs). We also discuss the possibility that systematic integration of NGS data may be employed to establish the rules of an “RNA editing code”, which may give us new insights into the functional consequences of RNA editing.

Keywords

ADAR Alternative splicing Gene regulation MicroRNA Next generation sequencing (NGS) RNA-seq RNA editing Small RNA-seq Transcriptional regulation

Introduction

RNA editing: a core constituent of the transcriptome

The transcriptome is the complete set of RNA molecules in a cell, expression of which is finely and dynamically regulated to meet the cellular needs associated with a particular developmental or physiological state. The field of transcriptomics entails investigating three main aspects of gene expression at the RNA level: the RNA species (e.g. mRNAs, non-coding RNAs, and small RNAs), the RNA transcript structure (e.g. start sites, splicing patterns, post-transcriptional processing), and RNA expression levels (quantitative changes within a specific context). While extensive efforts have been devoted to characterizing the transcriptional and post-transcriptional mechanisms that demarcate the transcriptome, RNA editing remains one of the less well explored steps in terms of its regulation and functional consequences.

RNA editing events, the majority of which are of the adenosine-to-inosine (A-to-I) type base changes, represent a core co-transcriptional process by which transcripts are covalently modified in a manner that results in an RNA sequence different from that encoded by the genomic DNA [13]. Such A-to-I conversion represents a form of genetic recoding, because the nucleoside inosine (I) is interpreted as guanosine (G) by cellular machines, such as those involved in splicing and translation. It thereby diversifies the cellular RNA signatures and functions. Interestingly, on the basis of its overabundance in the repetitive Alu elements and in the brain transcriptome [2, 4, 5], RNA editing has been viewed as a key determinant in primate evolution and development of higher brain functions [6].

Functions of ADARs, the RNA editing enzymes

The enzymatic process of A-to-I RNA editing is catalyzed primarily by the a denosine d ea minse acting on RNA (ADAR) family proteins that mediates deamination of adenosine to inosine in structured or double-stranded RNAs [2]. This metazoa-specific protein family comprises three members, ADAR1, ADAR2 (or ADARB1), and ADAR3 (or ADARB2). While no enzymatic activity has been demonstrated for ADAR3, it possesses conserved functional domain features and is highly conserved in vertebrates [7]. Conversely, activity of the editing-competent ADAR1 and ADAR2 is strictly dependent on the dsRNA-binding domain (dsRBD)-mediated recognition of RNA substrates [8], the secondary structure of which dictates editing site selectivity [911]. For certain dsRNAs, such as those encoded by repetitive elements and viral RNAs, A-to-I editing can also be nonselective and occur promiscuously. Mutation of the ADAR1 gene or altered A-to-I editing has been implicated in the regional onset of several human pathophysiological conditions, such as tumor malignancy [12, 13], the skin disease dyschromatosis symmetrica hereditaria [14], sporadic amyotrophic lateral sclerosis (ALS) [15], and neuropsychiatric disorders [16], reinforcing the biological significance of this event.

Review

Use of NGS technologies to decipher the RNA editome: a dramatic expansion of physical and functional evidence

Global and unequivocal identification of RNA editing targets represents a critical first step towards further understanding this vital co-transcriptional modification. In principle, editing sites could be inferred on the basis of sequence differences between RNA (or cDNA) and the genome DNA from which it is expressed. To this end, early bioinformatic approaches applied to publically archived sequence data provided glimpses of the RNA editome, revealing the distribution and structural characteristics of RNA editing events [13, 1719]. The recent advent of whole-transcriptome deep-sequencing technologies (e.g., RNA-Seq), along with their capacity to simultaneously assay the entire transcriptome at the nucleotide resolution, has prompted RNA editing discoveries in a global and quantitative manner [20]. However, despite their advantages, several technical issues – primarily sequencing errors, insufficient coverage of sequences, and potentially anomalous alignment of short-read sequences, have been known to confound the identification of authentic editing sites [21, 22]. Similar problems are also evident in detection of genomic single nucleotide polymorphisms (SNPs) [23].

To account for the likelihood of errors, subsequent analyses have been designed to incorporate quality control filters in their respective bioinformatics pipelines, as well as a larger extent of transcriptome sampling via sequencing depth. Consequently, recent studies reporting the use of target-specific RNA-Seq [24, 25], a combination of DNA capture and parallel sequencing [26], and transcriptome sequencing [2731] collectively have provided more verifiable, precise, and extensive documentation of editing sites in various biological contexts. Aside from further expanding the realm of the RNA editome, these large-scale datasets constitute an important framework for enhancing our understanding of the possible crosstalk between RNA editing and other steps in gene regulation. Here, we review these recent findings and examine the connection between RNA editing and transcript fate (Figure 1).
https://static-content.springer.com/image/art%3A10.1186%2F2045-3701-4-44/MediaObjects/13578_2014_Article_170_Fig1_HTML.jpg
Figure 1

Schematic depicting possible regulation of cellular RNA species by ADARs and RNA editing, as supported by recent large-scale NGS studies. Duplex structures that form on transcribed RNA molecules as a result of inverted sequence repeats (e.g. Alu or LINE elements) are potentially susceptible to ADARs binding and/or editing. Depending on the region where these structural substrates reside, RNA editing may lead to different fates of the mRNA and miRNA transcripts, as shown in this figure. Recent studies utilizing deep sequencing technologies have provided further insights into these regulatory pathways. For particular steps, such as transcription and translation, roles of RNA editing have not been clarified thus far. See text for further description.

Cis- vs. trans-acting regulation of alternative mRNA splicing by ADARs

A-to-I editing of pre-mRNA by ADAR proteins in a few cases has previously been linked to alternative expression of transcript isoforms. In a negative feedback auto-regulatory loop, ADAR2 may edit its own pre-mRNA to create an alternative isoform that encodes an otherwise dysfunctional short protein product [32]. In the case of the Gria2 (Glutamate receptor B) R/G editing site, which is one base upstream of a 5’-splice site, an A-to-I nucleotide change was demonstrated to influence the splicing rate [33]. The occurrence of RNA editing was also found to create or abolish critical cis-regulatory sequence that gives rise to alternatively spliced transcripts of the NARF[34] or PTPN6[35] genes, respectively. Finally, the observation that both ADAR1 and ADAR2 associate with spliceosome subunits and SR domain-containing splicing factors lends support to the idea that ADARs play a role in alternative splicing regulation [36].

Reinforcing such a link between the two RNA processing events, a more systematic approach utilizing high-throughput RNA-seq and exon-specific microarray analyses further revealed at the global scale that ADAR1 targets alternative splicing [37]. It was reported that hundreds of genes were found to undergo changes in their splicing patterns upon ADAR1 knockdown. While the authors observed direct editing of the splicing regulatory elements (SREs) within exons, and in few instances, the canonical splicing regulatory elements (i.e. acceptor, donor, and branch sites), lack of significant intersection excludes the possibility that alterations in splicing signal are the major mechanism for ADAR1-dependent widespread splicing alterations. Interestingly, genes that are alternatively spliced in response to ADAR1 knockdown are enriched for RNA splicing and processing functions. It is therefore likely that ADAR1 mediates its regulation indirectly through controlling expression of trans-acting factors implicated in splicing.

RNA editing regulates transcript stability and localization

RNA editing was previously hypothesized to mark aberrant and/or structured transcripts for retention in the nuclear compartment via a p54nrb-dependent mechanism [3840]. In the case of mouse cationic amino acid transporter 2 (CAT2) nuclear RNA (CTN-RNA), this spatio-temporal “trapping” mechanism is known to confer a stress-responsive expression. However, further studies on endogenous and reporter RNAs with inverted repeat dsRNA structure in 3’ UTR presented contrasting findings [41], showing that such secondary structure or A-to-I editing is not associated with the nuclear retention of RNAs. Relying on deep sequencing technologies, a recent report by Chen characterized and compared the nuclear and cytosolic editomes of seven human cell lines [42]. Findings from this global approach hinted at differential sub-cellular compartmentalization of the edited and unedited transcripts, but did argue against the role of editing in nuclear retention – for transcripts prone to nuclear-specific editing, editing status did not correlate with their localization.

Another means by which ADARs and/or RNA editing can determine transcript fate is at the level of stability. The aforementioned NGS-based studies all pointed to a significant enrichment of editing events in the 3’ UTR of target transcripts, a strong indication that editing is a functional determinant of transcript stability. Combining editome sequencing from ADAR1 knockdown cells and protein immunoprecipitation, Wang et al. strengthened this hypothesis by identifying an enrichment of HuR-binding sequences, which are implicated in transcript turnover and processing, around editing sites and on ADAR-bound transcripts, respectively [43]. They further demonstrated an interaction between ADAR1 and HuR. These results in combination reveal a functional cooperation between two RNA-binding proteins that coordinates different RNA processing steps.

RNA editing imposes a layer of reciprocal regulation on miRNA biology

In addition to messenger RNAs, editing is also known to take place on microRNAs (miRNAs), which are short RNAs of around 22 nucleotides that regulate gene expression post-transcriptionally. Owing to the double-stranded structure, the primary transcripts of miRNAs (pri-miRNAs) are therefore potential substrates for A-to-I RNA editing [44]. Early sequence analysis and target-specific RT-PCR experiments indeed identified nucleotide sequence variants in miRNAs [45, 46]. Powered by nucleotide resolution, small RNA-Seq studies have considerably broadened the spectrum of miRNA editome profiles [31, 47, 48]. These high-throughput analyses also uncovered editing sites distributed in the seed regions as well as a positional enrichment of editing at particular nucleotide of the mature sequence. Editing likely changes critical sequence and/or structural information within these small regulatory RNAs, and could consequently impact miRNA biogenesis and function. Indeed, functional relevance of miRNA editing has been illustrated for selected miRNAs, such as the redirection of miR-376 targeting and maturation [4951]. Intriguingly, Peng et al. also found that A-to-G variants are less overrepresented among the editing types in the miRNA sequences, implying the existence of a non-ADAR-based mechanism in this context [31]. Together, these observations strengthen the connection between RNA editing and miRNA-mediated regulation of gene expression. As deep sequencing data expands, this global approach will undoubtedly uncover additional editing events and underlying determinants that will enhance our understanding of this post-transcriptional crosstalk.

Reciprocally, given its prevalence in 3’ UTR, RNA editing is likely to affect in cis the binding of miRNA to targeted transcripts. In this capacity, transcriptome sequencing studies revealed an overlap between RNA editing sites and certain miRNA target sequences in this non-coding region [31, 42]. Moreover, based on sequence characterization, emergence of some of these base modifications were predicted to lead to the disruption or creation of miRNA binding sites in the 3’ UTR. A study by Wang et al. recently illustrated the functional relevance of this regional RNA editing, showing that this type of sequence alteration leads to interference of the target signals and consequently the binding of miR-30b-3p and miR-573 to the transcript of ARHGAP26[52]. Both high-throughput and gene-specific studies therefore imply that RNA editing may acquire functionality by conferring variable susceptibility to miRNA-mediated repression.

Does RNA editing regulate transcription?

Despite the seemingly extensive crosstalk between RNA editing and gene expression, transcriptional regulation remains one aspect that is the least explored to which ADAR1 may make a contribution. Intriguingly, in addition to the structural motifs for double-stranded RNA binding, ADAR1 also possess a Z-DNA-binding domain [53, 54], implying probable association with chromosomal domains that are amenable to transcription. However, as compared to its post-transcriptional functions, ADAR1’s direct role in transcriptional regulation has not been substantiated. ADAR1 is known to interact with nuclear factor 90 (NF90), a transcription and translation regulator, and stimulate its function in gene expression [55]. Other evidence for ADAR1’s involvement in transcriptional regulation, albeit indirect, was provided by the recent finding of an editing-mediated recoding event on the transcript of Glioma-associated oncogene (GLI1), a transcriptional effector of the Hedgehog (HH) signaling [56]. The consequent single amino acid substitution (Arg701 to Gly) alters GLI1’s transcriptional activity, response to upstream kinase, and function in cell growth. Perhaps in part due to these reported roles in transcription, RNA-seq experiments performed on ADAR1 knockdown cells revealed altered levels of RNA transcripts [43]. However, expression profiling of this type provides information pertaining only to the “steady-state” level of RNA expression. Further revealing the role of ADAR1 in transcription may come from global techniques that measure the synthesis rates of nascent transcripts, such as the metabolic labeling (4sU-Seq) [57] and global nuclear run-on (GRO-Seq) [58] methods.

Conclusion

Future perspectives

In summary, great progress has been made with regard to identifying RNA editing sites in the non-coding components of the transcriptome. We now know that crosstalk between A-to-I editing and miRNA is more extensive than previously thought. With the growing body of sequencing data, one of the outstanding issues to address is the biological and regulatory significance of these sequence-altering events, particularly in the miRNA gene silencing process that stringently relies on sequence complementarity. Predicting the functional outcome of RNA editing remains a challenge, and may require thorough bioinformatics algorithms that cross-compare both sequence and quantitative information on all constituents of the transcriptome derived from the same samples. This type of integrative investigation is expected to bring to light new layers of target selection by miRNAs, a better understanding of miRNA maturation and stability, and insights into the regulation of the post-transcriptional gene silencing mechanisms.

Similar analyses and studies can also be extended to deciphering the impact of RNA editing on post-transcriptional attributes of the transcripts, such as alternative splicing and transcript stability. Despite our knowledge of the prevalent distribution of RNA editing in non-coding regions of genes, evidence is still lacking as to how these binary nucleotide changes in combination could contribute as regulatory switches for gene and isoform expression. Also, as translation is the functional readout of gene expression, it is presently unclear whether RNA editing in the non-coding regulatory regions could influence the rate and/or output of protein translation. To address these issues, high-throughput sequencing studies that are designed to monitor ribosome occupancy on protein-coding transcripts [59] may represent an ideal approach for characterizing the effect of ADARs and RNA editing. Moreover, functional implications of RNA editing per se on gene regulation cannot be deciphered solely based on the gene knockdown or knockout manipulation, due to the notion that ADARs may have editing-independent functions [60]; rather, other means of directly impairing editing, such as steric inhibition by antisense oligonucleotides [61, 62], may be valuable in strengthening the regulatory role of RNA editing.

Furthermore, as sequencing data acquired from large-scale studies are providing a more comprehensive view of the cellular transcriptomes, we are now poised to explore the uncharted territory of RNA editomes – including repetitive elements of transposons and retrotransposons as well as other small RNAs, such as endogenous small RNA (esiRNA). Finally, given that RNA editing is highly abundant in primates [24, 63], the depth of sequencing information provided by NGS will facilitate meaningful cross-species comparisons with our close evolutionary relatives, potentially giving important insights into the selection of RNA editing as a mechanism utilized by organisms during evolution within the context of gene regulation [64]. Such analysis would be particularly important owing to the recent observation that recoding RNA editing events in general are nonadaptive [65]. “Comparative editomes” – parallels within and diversification of the editome across multiple primate species – will thus be a framework for further interrogation into the functional significance of particular editing events and perhaps of the process as a whole [6567]. Viewed together, these genome-wide investigations based upon deep sequencing are needed to better understand the sequence and/or structural determinants underlying the “RNA editing codes”, taking our understanding to new levels at which functional consequences of RNA editing can be explored in a global manner.

Declarations

Acknowledgement

We are grateful to members of the BC-MT laboratory for critical reading of the article and important discussions. We thank Hsiao-Jung Chen for providing the artwork in Figure 1. This work was supported by grants from the National Science Council of Taiwan (NSC102-2321-B-182-007 and NSC101-2320-B-182-036-MY3 to BC-MT; NSC 102-2311-B-182-004 to SCS), Chang Gung Memorial Hospital (CMRPD1A0323 and CMRPD1C0841 to BC-MT; CMRPD1B0313 and CMRPD1C0611 to SCS), National Health Research Institute of Taiwan (NHRI-EX103-10321SI), and the Ministry of Education, Taiwan.

Authors’ Affiliations

(1)
Graduate Institute of Biomedical Sciences
(2)
Department of Biochemistry
(3)
Department of Biomedical Sciences, College of Medicine, Tao-Yuan
(4)
Molecular Medicine Research Center, Chang Gung University, Tao-Yuan
(5)
Department of Otolaryngology, Chang Gung Memorial Hospital at Lin-Kuo, Tao-Yuan

References

  1. Hundley HA, Bass BL: ADAR editing in double-stranded UTRs and other noncoding RNA sequences. Trends Biochem Sci. 2010, 35: 377-383.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Nishikura K: Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010, 79: 321-349.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Farajollahi S, Maas S: Molecular diversity through RNA editing: a balancing act. Trends Genet. 2010, 26: 221-230.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Jepson JE, Reenan RA: RNA editing in regulating gene expression in the brain. Biochim Biophys Acta. 2008, 1779: 459-470.View ArticlePubMedGoogle Scholar
  5. Osenberg S, Paz Yaacov N, Safran M, Moshkovitz S, Shtrichman R, Sherf O, Jacob-Hirsch J, Keshet G, Amariglio N, Itskovitz-Eldor J, Rechavi G: Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing. PLoS One. 2010, 5: e11173PubMed CentralView ArticlePubMedGoogle Scholar
  6. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J, Amariglio N, Eisenberg E, Rechavi G: Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc Natl Acad Sci U S A. 2010, 107: 12174-12179.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K: A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA. 2000, 6: 755-767.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Valente L, Nishikura K: RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J Biol Chem. 2007, 282: 16054-16061.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Lehmann KA, Bass BL: The importance of internal loops within RNA substrates of ADAR1. J Mol Biol. 1999, 291: 1-13.View ArticlePubMedGoogle Scholar
  10. Wang Q, O’Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K: Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem. 2000, 74: 1290-1300.View ArticlePubMedGoogle Scholar
  11. Lomeli H, Mosbacher J, Melcher T, Hoger T, Geiger JR, Kuner T, Monyer H, Higuchi M, Bach A, Seeburg PH: Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science. 1994, 266: 1709-1713.View ArticlePubMedGoogle Scholar
  12. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Kruspsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G: Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007, 17: 1586-1595.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A: Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 2004, 14: 1719-1725.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, Tomita Y: Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet. 2003, 73: 693-699.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Kwak S, Kawahara Y: Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J Mol Med. 2005, 83: 110-120.View ArticlePubMedGoogle Scholar
  16. Schmauss C: Regulation of serotonin 2C receptor pre-mRNA editing by serotonin. Int Rev Neurobiol. 2005, 63: 83-100.View ArticlePubMedGoogle Scholar
  17. Athanasiadis A, Rich A, Maas S: Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2004, 2: e391PubMed CentralView ArticlePubMedGoogle Scholar
  18. Blow M, Futreal AP, Wooster R, Stratton MR: A survey of RNA editing in human brain. Genome Res. 2004, 14: 2379-2387.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, Olshansky M, Rechavi G, Jantsch MF: Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol. 2004, 22: 1001-1005.View ArticlePubMedGoogle Scholar
  20. Ju YS, Kim JI, Kim S, Hong D, Park H, Shin JY, Lee S, Lee WC, Yu SB, Park SS, Seo SH, Yun JY, Kim HJ, Lee DS, Yavartanoo M, Kang HP, Gokcumen O, Govindaraju DR, Jung JH, Chong H, Yang KS, Kim H, Lee C, Seo JS: Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals. Nat Genet. 2011, 43: 745-752.View ArticlePubMedGoogle Scholar
  21. Nekrutenko A, Taylor J: Next-generation sequencing data interpretation: enhancing reproducibility and accessibility. Nat Rev Genet. 2012, 13: 667-672.View ArticlePubMedGoogle Scholar
  22. Pachter L: A closer look at RNA editing. Nat Biotechnol. 2012, 30: 246-247.View ArticlePubMedGoogle Scholar
  23. Cirulli ET, Singh A, Shianna KV, Ge D, Smith JP, Maia JM, Heinzen EL, Goedert JJ, Goldstein DB: Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol. 2010, 11: R57PubMed CentralView ArticlePubMedGoogle Scholar
  24. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J, Amariglio N, Eisenberg E, Rechavi G: Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc Natl Acad Sci U S A. 2010, 107: 12174-12179.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Wahlstedt H, Daniel C, Enstero M, Ohman M: Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res. 2009, 19: 978-986.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, LeProust E, Zhang K, Gao Y, Church GM: Genome-Wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science. 2009, 324: 1210-1213.View ArticlePubMedGoogle Scholar
  27. Bahn JH, Lee JH, Li G, Greer C, Peng G, Xiao X: Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res. 2012, 22: 142-150.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Park E, Williams B, Wold BJ, Mortazavi A: RNA editing in the human ENCODE RNA-seq data. Genome Res. 2012, 22: 1626-1633.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Ramaswami G, Zhang R, Piskol R, Keegan LP, Deng P, O’Connell MA, Li JB: Identifying RNA editing sites using RNA sequencing data alone. Nat Methods. 2013, 10: 128-132.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Ramaswami G, Lin W, Piskol R, Tan MH, Davis C, Li JB: Accurate identification of human Alu and non-Alu RNA editing sites. Nat Methods. 2012, 9: 579-581.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Peng Z, Cheng Y, Tan BC, Kang L, Tian Z, Zhu Y, Zhang W, Liang Y, Hu X, Tan X, Guo J, Dong Z, Bao L, Wang J: Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol. 2012, 30: 253-260.View ArticlePubMedGoogle Scholar
  32. Rueter SM, Dawson TR, Emeson RB: Regulation of alternative splicing by RNA editing. Nature. 1999, 399: 75-80.View ArticlePubMedGoogle Scholar
  33. Schoft VK, Schopoff S, Jantsch MF: Regulation of glutamate receptor B pre-mRNA splicing by RNA editing. Nucleic Acids Res. 2007, 35: 3723-3732.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Lev-Maor G, Sorek R, Levanon EY, Paz N, Eisenberg E, Ast G: RNA-editing-mediated exon evolution. Genome Biol. 2007, 8: R29PubMed CentralView ArticlePubMedGoogle Scholar
  35. Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L: RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet. 2000, 9: 2297-2304.View ArticlePubMedGoogle Scholar
  36. Raitskin O, Cho DS, Sperling J, Nishikura K, Sperling R: RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery. Proc Natl Acad Sci U S A. 2001, 98: 6571-6576.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Solomon O, Oren S, Safran M, Deshet-Unger N, Akiva P, Jacob-Hirsch J, Cesarkas K, Kabesa R, Amariglio N, Unger R, Rechavi G, Eyal E: Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR). RNA. 2013, 19: 591-604.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Zhang Z, Carmichael GG: The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell. 2001, 106: 465-475.View ArticlePubMedGoogle Scholar
  39. Prasanth KV, Prasanth SG, Xuan Z, Hearn S, Freier SM, Bennett CF, Zhang MQ, Spector DL: Regulating gene expression through RNA nuclear retention. Cell. 2005, 123: 249-263.View ArticlePubMedGoogle Scholar
  40. Chen LL, DeCerbo JN, Carmichael GG: Alu element-mediated gene silencing. EMBO J. 2008, 27: 1694-1705.PubMed CentralView ArticlePubMedGoogle Scholar
  41. Hundley HA, Krauchuk AA, Bass BL: C. elegans and H. sapiens mRNAs with edited 3’ UTRs are present on polysomes. RNA. 2008, 14: 2050-2060.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Chen L: Characterization and comparison of human nuclear and cytosolic editomes. Proc Natl Acad Sci U S A. 2013, 110: E2741-E2747.PubMed CentralView ArticlePubMedGoogle Scholar
  43. Wang IX, So E, Devlin JL, Zhao Y, Wu M, Cheung VG: ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression. Cell Rep. 2013, 5: 849-860.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Finnegan EF, Pasquinelli AE: MicroRNA biogenesis: Regulating the regulators. Crit Rev Biochem Mol Biol. 2013, 48: 51-68.PubMed CentralView ArticlePubMedGoogle Scholar
  45. Kawahara Y, Megraw M, Kreider E, Iizasa H, Valente L, Hatzigeorgiou AG, Nishikura K: Frequency and fate of microRNA editing in human brain. Nucleic Acids Res. 2008, 36: 5270-5280.PubMed CentralView ArticlePubMedGoogle Scholar
  46. Blow MJ, Grocock RJ, van Dongen S, Enright AJ, Dicks E, Futreal PA, Wooster R, Stratton MR: RNA editing of human microRNAs. Genome Biol. 2006, 7: R27PubMed CentralView ArticlePubMedGoogle Scholar
  47. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP: Mammalian microRNAs: Experimental evaluation of novel and previously annotated genes. Genes Dev. 2010, 24: 992-1009.PubMed CentralView ArticlePubMedGoogle Scholar
  48. Alon S, Mor E, Vigneault F, Church GM, Locatelli F, Galeano F, Gallo A, Shomron N, Eisenberg E: Systematic identification of edited microRNAs in the human brain. Genome Res. 2012, 22: 1533-1540.PubMed CentralView ArticlePubMedGoogle Scholar
  49. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K: Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 2007, 315: 1137-1140.PubMed CentralView ArticlePubMedGoogle Scholar
  50. Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT, Wang S: Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. J Clin Invest. 2012, 122: 4059-4076.PubMed CentralView ArticlePubMedGoogle Scholar
  51. Nachmani D, Zimmermann A, Oiknine Djian E, Weisblum Y, Livneh Y, Le Khanh VT, Galun E, Horejsi V, Isakov O, Shomron N, Wolf DG, Hengel H, Mandelboim O: MicroRNA editing facilitates immune elimination of HCMV infected cells. PLoS Pathog. 2014, 10: e1003963PubMed CentralView ArticlePubMedGoogle Scholar
  52. Wang Q, Hui H, Guo Z, Zhang W, Hu Y, He T, Tai Y, Peng P, Wang L: ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding. RNA. 2013, 19: 1525-1536.PubMed CentralView ArticlePubMedGoogle Scholar
  53. Herbert A, Schade M, Lowenhaupt K, Alfken J, Schwartz T, Shlyakhtenko LS, Lyubchenko YL, Rich A: The Zalpha domain from human ADAR1 binds to the Z-DNA conformer of many different sequences. Nucleic Acids Res. 1998, 26: 3486-3493.PubMed CentralView ArticlePubMedGoogle Scholar
  54. Barraud P, Allain FH: ADAR proteins: double-stranded RNA and Z-DNA binding domains. Curr Top Microbiol Immunol. 2012, 353: 35-60.PubMed CentralPubMedGoogle Scholar
  55. Nie Y, Ding L, Kao PN, Braun R, Yang JH: ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol Cell Biol. 2005, 25: 6956-6963.PubMed CentralView ArticlePubMedGoogle Scholar
  56. Shimokawa T, Rahman MF, Tostar U, Sonkoly E, Stahle M, Pivarcsi A, Palaniswamy R, Zaphiropoulos PG: RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol. 2013, 10: 321-333.PubMed CentralView ArticlePubMedGoogle Scholar
  57. Rabani M, Levin JZ, Fan L, Adiconis X, Raychowdhury R, Garber M, Gnirke A, Nusbaum C, Hacohen N, Friedman N, Amit I, Regev A: Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol. 2011, 29: 436-442.PubMed CentralView ArticlePubMedGoogle Scholar
  58. Escoubet-Lozach L, Benner C, Kaikkonen MU, Lozach J, Heinz S, Spann NJ, Crotti A, Stender J, Ghisletti S, Reichart D, Cheng CS, Luna R, Ludka C, Sasik R, Garcia-Bassets I, Hoffmann A, Subramaniam S, Hardiman G, Rosenfeld MG, Glass CK: Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011, 7: e1002401PubMed CentralView ArticlePubMedGoogle Scholar
  59. Wang T, Cui Y, Jin J, Guo J, Wang G, Yin X, He QY, Zhang G: Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific. Nucleic Acids Res. 2013, 41: 4743-4754.PubMed CentralView ArticlePubMedGoogle Scholar
  60. Heale BS, Keegan LP, McGurk L, Michlewski G, Brindle J, Stanton CM, Caceres JF, O’Connell MA: Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J. 2009, 28: 3145-3156.PubMed CentralView ArticlePubMedGoogle Scholar
  61. Mizrahi RA, Schirle NT, Beal PA: Potent and selective inhibition of A-to-I RNA editing with 2’-O-methyl/locked nucleic acid-containing antisense oligoribonucleotides. ACS Chem Biol. 2013, 8: 832-839.PubMed CentralView ArticlePubMedGoogle Scholar
  62. Penn AC, Balik A, Greger IH: Steric antisense inhibition of AMPA receptor Q/R editing reveals tight coupling to intronic editing sites and splicing. Nucleic Acids Res. 2013, 41: 1113-1123.PubMed CentralView ArticlePubMedGoogle Scholar
  63. Eisenberg E, Nemzer S, Kinar Y, Sorek R, Rechavi G, Levanon EY: Is abundant A-to-I RNA editing primate-specific?. Trends Genet. 2005, 21: 77-81.View ArticlePubMedGoogle Scholar
  64. Dheilly NM, Adema C, Raftos DA, Gourbal B, Grunau C, Du Pasquier L: No more non-model species: The promise of next generation sequencing for comparative immunology. Dev Comp Immunol. 2014, 45: 56-66.PubMed CentralView ArticlePubMedGoogle Scholar
  65. Xu G, Zhang J: Human coding RNA editing is generally nonadaptive. Proc Natl Acad Sci U S A. 2014, 111: 3769-3774.PubMed CentralView ArticlePubMedGoogle Scholar
  66. Chen JY, Peng Z, Zhang R, Yang XZ, Tan BC, Fang H, Liu CJ, Shi M, Ye ZQ, Zhang YE, Deng M, Zhang X, Li CY: RNA editome in rhesus macaque shaped by purifying selection. PLoS Genet. 2014, 10: e1004274PubMed CentralView ArticlePubMedGoogle Scholar
  67. Zhang SJ, Liu CJ, Yu P, Zhong X, Chen JY, Yang X, Peng J, Yan S, Wang C, Zhu X, Xiong J, Zhang YE, Tan BC, Li CY: Evolutionary interrogation of human biology in well-annotated genomic framework of rhesus macaque. Mol Biol Evol. 2014, 31: 1309-1324.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Liu et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement